PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer.
暂无分享，去创建一个
P. Carroll | J. Brooks | P. Nelson | J. McKenney | M. Gleave | I. Thompson | L. Fazli | A. Hurtado-coll | L. True | Ziding Feng | D. Troyer | S. Hawley | D. Lin | T. Lotan | R. Lance | J. Simko | C. L. Morais | Wei Wei | Sarah T. Hawley | Carlos L. Morais | I. Thompson